54943 North Main Street
Mattawan, MI 49071-9399
Phone: 269-668-3336 ext. 1550
Fax: 269-668-4151
www.mpiresearch.com
Contact Person: Brad Dayton
Email: Brad.Dayton@mpiresearch.com
|
MPI
Research Teams with NYBA
MPI Research
presents and exhibits at the 16th
Annual Meeting of the New York Biotechnology
Association (NYBA) on April 10, 2007
|
| 2007-04-05 |
MATTAWAN, April 5,
2007: MPI Research is pleased
to be an integral part of the 16th NYBA
annual meeting, being held on April 10,
2007 at the Marriott Marquis Hotel in New
York City. Stephen Frantz, PhD, DABT, MPI
Research Director of Pharmaceutical Development
and Senior Principal Study Director, will
be one of three panelists discussing “FDA
Requirements for New Drug Development – Enabling
Your IND.” NYBA will sponsor fifteen
panel discussions on crucial and timely
topics impacting the biotech industry of
both today and tomorrow.
“MPI Research
is proud to participate in this important
meeting,” says James
Laveglia, PhD, Vice President of Research
and Development at MPI Research. “A
didactic approach such as this is one of
many ways we help the biotechnology industry
on their journey towards new product development.
It is an honor to support NYBA’s mission
of advancing the success of the biotech industry.”
The
goal of NYBA (www.nyba.org)
is to advance the success of the biotech
industry in the state of New York. The organization
also advocates on behalf of this industry
among policymakers. With over 250 New York
biotech companies as member organizations,
NYBA will continue to provide opportunities
for learning and collegiality under its manner
of ”The
Cure Stops Here®.”
MPI Research,
with headquarters in Mattawan, Michigan,
is one of the worlds leading providers of
comprehensive preclinical research and development
services. More information on the company’s
services can be obtained through the website
at www.mpiresearch.com.
Home | News
|
